{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:18:02Z","timestamp":1793834282019,"version":"4.6.1"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["BOF-GOA ID 41739"],"award-info":[{"award-number":["BOF-GOA ID 41739"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["50389"],"award-info":[{"award-number":["50389"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cytogfr.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:37:59Z","timestamp":1748374679000},"page":"20-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology"],"prefix":"10.1016","volume":"84","author":[{"given":"Alexandro A.","family":"Bufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Papait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta R.","family":"Silini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-6499","authenticated-orcid":false,"given":"Peter","family":"Ponsaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib1","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.74.6.2256","article-title":"Amino acid sequence of human platelet factor 4","volume":"74","author":"Deuel","year":"1977","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.cytogfr.2025.05.003_bib2","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1073\/pnas.87.14.5238","article-title":"A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines","volume":"87","author":"Farber","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/bbrc.1993.1403","article-title":"HuMig: a new human member of the chemokine family of cytokines","volume":"192","author":"Farber","year":"1993","journal-title":"Biochem Biophys. Res Commun."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon\u2013inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6021","key":"10.1016\/j.cytogfr.2025.05.003_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"\u03b3-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","article-title":"Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)","volume":"166","author":"Luster","year":"1987","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib7","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.200324235","article-title":"Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation","volume":"33","author":"Xanthou","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J. Exp. Med."},{"issue":"14","key":"10.1016\/j.cytogfr.2025.05.003_bib9","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1073\/pnas.95.14.8205","article-title":"The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3","volume":"95","author":"Soto","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"D1","key":"10.1016\/j.cytogfr.2025.05.003_bib10","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2022.882017","article-title":"Evolution, expression and functional analysis of CXCR3 in neuronal and cardiovascular diseases: a narrative review","volume":"10","author":"Satarkar","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib12","article-title":"Mechanisms of regulation of the chemokine-receptor network","volume":"18","author":"Stone","year":"2017"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib13","article-title":"G protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.05.003_bib15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib16","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping","volume":"173","author":"Ehlert","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","article-title":"Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+\u2009regulatory T cells","volume":"180","author":"Lim","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib19","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V\u03b41 and V\u03b42 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1\u2013infected patients: competition by HIV-1 Tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.05.003_bib20","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"\u201cLymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization,\u201d","volume":"28","author":"Loetscher","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib21","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2005-04-1393","article-title":"T-bet is required for optimal proinflammatory CD4+\u2009T-cell trafficking","volume":"106","author":"Lord","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.201203-0508OC","article-title":"CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin","volume":"187","author":"Ichikawa","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.165.3.1548","article-title":"CXCR3 expression and activation of eosinophils: role of IFN-\u03b3-inducible protein-10 and monokine induced by IFN-\u03b3","volume":"165","author":"Jinquan","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells","volume":"81","author":"Garc\u00eda-L\u00f3pez","year":"2001","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0306-4522(00)00024-5","article-title":"Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons","volume":"97","author":"Coughlan","year":"2000","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2990.2001.00312.x","article-title":"CXCR3 expression in human central nervous system diseases","volume":"27","author":"Goldberg","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.02.116","article-title":"MAP kinase regulation of IP10\/CXCL10 chemokine gene expression in microglial cells","volume":"1086","author":"Shen","year":"2006","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.cytogfr.2025.05.003_bib28","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1158\/0008-5472.CAN-05-4345","article-title":"Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer","volume":"66","author":"Datta","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib29","doi-asserted-by":"crossref","first-page":"C34","DOI":"10.1152\/ajpcell.00441.2005","article-title":"CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways","volume":"291","author":"Shahabuddin","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.05.003_bib30","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3","volume":"276","author":"Bonacchi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","article-title":"The biology of chemokines and their receptors","volume":"18","author":"Rossi","year":"2000","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V93.1.25","article-title":"Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1\/WAF1)","volume":"93","author":"Gentilini","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2249.2007.03344.x","article-title":"The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity","volume":"148","author":"Colobran","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"05","key":"10.1016\/j.cytogfr.2025.05.003_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0070-2153(05)68006-4","article-title":"Chemokine receptor CXCR3: an unexpected enigma","volume":"68","author":"Liu","year":"2005","journal-title":"Curr. Top. Dev. Biol."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.05.003_bib35","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1128\/JVI.79.13.8295-8302.2005","article-title":"Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.05.003_bib36","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"29","key":"10.1016\/j.cytogfr.2025.05.003_bib38","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M403595200","article-title":"Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function","volume":"279","author":"Colvin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib39","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.bbapap.2014.08.004","article-title":"N-terminal region of human chemokine receptor CXCR3: Structural analysis of CXCR3(1\u201348) by experimental and computational studies","volume":"1844","author":"Raucci","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Proteins Proteom."},{"issue":"33","key":"10.1016\/j.cytogfr.2025.05.003_bib40","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1021\/bi026020q","article-title":"The CXCR3 binding chemokine IP-10\/CXCL10: structure and receptor interactions","volume":"41","author":"Booth","year":"2002","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"10.1016\/j.cytogfr.2025.05.003_bib41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molimm.2009.09.013","article-title":"Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design","volume":"47","author":"Trotta","year":"2009","journal-title":"Mol. Immunol."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.05.003_bib42","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1128\/MCB.00556-06","article-title":"CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis","volume":"26","author":"Colvin","year":"2006","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1074\/jbc.M209470200","article-title":"Structure-function relationship between the human chemokine receptor CXCR3 and its ligands","volume":"278","author":"Clark-Lewis","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejcb.2017.02.001","article-title":"The \u03b24GalT1 affects the fibroblast-like synoviocytes invasion in rheumatoid arthritis by modifying N-linked glycosylation of CXCR3","volume":"96","author":"Sun","year":"2017","journal-title":"Eur. J. Cell Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: Redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib46","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.177.3.1855","article-title":"Both CXCR3 and CXCL10\/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus","volume":"177","author":"Hsieh","year":"2006","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.cytogfr.2025.05.003_bib47","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","article-title":"Neuronal CXCL10 directs CD8 +\u2009T-cell recruitment and control of west nile virus encephalitis","volume":"79","author":"Klein","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000369","article-title":"IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection","volume":"5","author":"Nie","year":"2009","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib49","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.180.2.1217","article-title":"Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency","volume":"180","author":"Miu","year":"2008","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.05.003_bib50","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.4049\/jimmunol.0903831","article-title":"CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors","volume":"184","author":"Rosenblum","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-3083.1994.tb03477.x","article-title":"The Role of CD4+\u2009T cells in cell-mediated immunity to LCM V: studies in MHC class I and class II deficient mice","volume":"40","author":"Christensen","year":"1994","journal-title":"Scand. J. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib55","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.3201\/eid2612\/201792","article-title":"Lymphocytic choriomeningitis virus infections and seroprevalence, southern Iraq","volume":"26","author":"Alburkat","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.spen.2012.02.002","article-title":"Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult","volume":"19","author":"Bonthius","year":"2012","journal-title":"Semin Pedia Neurol."},{"issue":"20","key":"10.1016\/j.cytogfr.2025.05.003_bib57","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1523\/JNEUROSCI.0123-04.2004","article-title":"Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3","volume":"24","author":"Christensen","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/13550289909029747","article-title":"Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus","volume":"5","author":"Asensio","year":"1999","journal-title":"J. Neurovirol"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib59","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/jvi.71.10.7832-7840.1997","article-title":"Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis","volume":"71","author":"Asensio","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib60","article-title":"Cell-Mediated","author":"Lemos","year":"2009","journal-title":"Inflamm. Cent. Nerv. Syst."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib61","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.4049\/jimmunol.176.7.4235","article-title":"Cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system 1","volume":"176","author":"Christensen","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib62","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.182.2.1079","article-title":"Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokine-chemokine-cytokine-chemokine cascade","volume":"182","author":"Christensen","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/vim.2008.0057","article-title":"Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-armstrong","volume":"21","author":"Hofer","year":"2008","journal-title":"Viral Immunol."},{"issue":"9903","key":"10.1016\/j.cytogfr.2025.05.003_bib64","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2025.05.003_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.814362","article-title":"Worldwide occurrence of HIV-associated neurocognitive disorders and its associated factors: a systematic review and meta-analysis","volume":"13","author":"Zenebe","year":"2022","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/cells8101245","article-title":"New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system","volume":"8","author":"Rojas-Celis","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/brain\/awy339","article-title":"Blood\u2013brain barrier pericytes as a target for HIV-1 infection","volume":"142","author":"Bertrand","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib68","first-page":"1535","article-title":"Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells","volume":"90","author":"Dhawan","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib69","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood\u2013brain barrier: a potential mechanism of HIV\u2013CNS invasion and neuroAIDS","volume":"26","author":"Eugenin","year":"2006","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib70","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/cells11121943","article-title":"Aberrant synaptic pruning in CNS diseases: a critical player in HIV-associated neurological dysfunction?","volume":"11","author":"Watson","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae179","article-title":"Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids","volume":"3","author":"Kong","year":"2024","journal-title":"PNAS Nexus"},{"issue":"15","key":"10.1016\/j.cytogfr.2025.05.003_bib72","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3390\/cells11152379","article-title":"Identification, quantification, and characterization of HIV-1 reservoirs in the human brain","volume":"11","author":"Donoso","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.05.003_bib73","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3390\/ijms25094697","article-title":"HIV-associated neurocognitive disorder: a look into cellular and molecular pathology","volume":"25","author":"Thompson","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/viro.1999.9780","article-title":"Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies","volume":"259","author":"Altmeyer","year":"1999","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib75","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.4049\/jimmunol.178.5.3226","article-title":"Functional synergy between CD40 Ligand and HIV-1 tat contributes to inflammation: implications in HIV type 1 dementia","volume":"178","author":"Sui","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/cimm.1996.0217","article-title":"The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures","volume":"172","author":"Kong","year":"1996","journal-title":"Cell Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.01543.x","article-title":"HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium","volume":"84","author":"Toborek","year":"2003","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.05.003_bib78","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1128\/JVI.75.15.7067-7077.2001","article-title":"Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10\/IP-10 gene expression by astrocytes in vivo and in vitro","volume":"75","author":"Asensio","year":"2001","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.cytogfr.2025.05.003_bib79","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1128\/JVI.74.19.9214-9221.2000","article-title":"Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes","volume":"74","author":"Kutsch","year":"2000","journal-title":"J. Virol."},{"issue":"4\u20135","key":"10.1016\/j.cytogfr.2025.05.003_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-0684.2003.00030.x","article-title":"Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis","volume":"32","author":"Sui","year":"2003","journal-title":"J. Med Prima"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.05.003_bib81","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/eji.1830271004","article-title":"Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-\u03b3 inducible protein-10 and monocyte chemotactic protein-1","volume":"27","author":"Lahrtz","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-5728(98)00223-9","article-title":"Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-\u03b3 inducible protein 10","volume":"93","author":"Kolb","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.05.003_bib83","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/aid.2020.0203","article-title":"Impact of plasma IP-10\/CXCL10 and RANTES\/CCL5 levels on neurocognitive function in hiv treatment-naive patients","volume":"37","author":"Ruhanya","year":"2021","journal-title":"AIDS Res Hum. Retrovir."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.05.003_bib84","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/glia.20801","article-title":"Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes","volume":"57","author":"Williams","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.cytogfr.2025.05.003_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-239","article-title":"Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator","volume":"9","author":"Mehla","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005709","article-title":"HIV-1 Tat Co-operates with IFN-\u03b3 and TNF-\u03b1 to Increase CXCL10 in human astrocytes","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib87","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1460-9568.2006.04631.x","article-title":"CXCL10-induced cell death in neurons: role of calcium dysregulation","volume":"23","author":"Sui","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01977","article-title":"Effector CD8 T cell-dependent zika virus control in the CNS: a matter of time and numbers","volume":"11","author":"Nazerai","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika virus infection in man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib90","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1402143","article-title":"Maternal-fetal transmission of the zika virus: An intriguing interplay","volume":"6","author":"Zanluca","year":"2018","journal-title":"Tissue Barriers"},{"issue":"_10","key":"10.1016\/j.cytogfr.2025.05.003_bib91","doi-asserted-by":"crossref","first-page":"S891","DOI":"10.1093\/infdis\/jix448","article-title":"Zika virus infection in pregnancy: maternal, fetal, and neonatal considerations","volume":"216","author":"Zorrilla","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib92","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200047","article-title":"Guillain-barr\u00e9 syndrome following zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies","volume":"10","author":"Davies","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41572-024-00580-4","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"10","author":"Leonhard","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib94","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mus.23829","article-title":"The role of chemokines in guillain\u2013barr\u00e9 syndrome","volume":"48","author":"Chiang","year":"2013","journal-title":"Muscle Nerve"},{"issue":"5692","key":"10.1016\/j.cytogfr.2025.05.003_bib95","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/277140a0","article-title":"Identification of the neuritogen for experimental allergic neuritis","volume":"277","author":"KADLUBOWSKI","year":"1979","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(87)90235-8","article-title":"P0 myelin protein produces experimental allergic neuritis in Lewis rats","volume":"79","author":"Milner","year":"1987","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib97","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41594-023-01175-5","article-title":"Structural insights into the activation and inhibition of CXC chemokine receptor 3","volume":"31","author":"Jiao","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"18","key":"10.1016\/j.cytogfr.2025.05.003_bib98","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib99","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib100","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4103\/1673-5374.327323","article-title":"SARS-CoV-2 involvement in central nervous system tissue damage","volume":"17","author":"Haidar","year":"2022","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.cytogfr.2025.05.003_bib101","article-title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome","volume":"06","author":"Yang","year":"2020","journal-title":"Mar"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.90.3.181","article-title":"A murine viruS (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin","volume":"90","author":"Cheever","year":"1949","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1073858420939033","article-title":"COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator?","volume":"27","author":"Oliviero","year":"2021","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib104","first-page":"45","article-title":"Lyme borreliosis]","volume":"55","author":"Weiss","year":"1998","journal-title":"Ther. Umsch."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.17219\/acem\/68846","article-title":"CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration","volume":"27","author":"Koper","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s004150050214","article-title":"Neuroborreliosis","volume":"245","author":"Kaiser","year":"1998","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2005.03.005","article-title":"Increased expression of CXCR3 and CCR5 on memory CD4+\u2009T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11","volume":"163","author":"Lepej","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2013.11.002","article-title":"Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis","volume":"157","author":"Moniuszko","year":"2014","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-2094-8-36","article-title":"Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study","volume":"8","author":"Henningsson","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03336-z","article-title":"Pathophysiology and neurologic sequelae of cerebral malaria","volume":"19","author":"Schiess","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib111","first-page":"6369","volume":"169","author":"Van Rooijen","year":"2019","journal-title":"Pathog. Role Brain-Sequestered"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.05.003_bib112","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.4049\/jimmunol.178.9.5779","article-title":"Brain during plasmodium berghei-mediated cerebral malaria 1","volume":"178","author":"Hansen","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib113","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/eji.200737906","article-title":"CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-\u03b3-induced chemokines","volume":"38","author":"Van den Steen","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib114","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1073\/pnas.0801544105","article-title":"Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria","volume":"105","author":"Campanella","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-021-01152-9","article-title":"Epidemiology of brain and other CNS tumors","volume":"21","author":"Ostrom","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.05.003_bib117","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain Tumors","volume":"131","author":"McFaline-Figueroa","year":"2018","journal-title":"Am. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2008.04.029","article-title":"Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation","volume":"199","author":"Maru","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib119","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4103\/0973-1482.153657","article-title":"Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: a tissue microarray-based comparison","volume":"12","author":"Sharma","year":"2016","journal-title":"J. Cancer Res Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/carcin\/bgq224","article-title":"Chemokine receptor CXCR3 promotes growth of glioma","volume":"32","author":"Liu","year":"2011","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib121","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib122","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1349-7006.2006.00208.x","article-title":"Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy","volume":"97","author":"Szatmari","year":"2006","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-71857-3","article-title":"Downregulation of the CCL2\/CCR2 and CXCL10\/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma","volume":"10","author":"Shono","year":"2020","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.05.003_bib124","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","article-title":"Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation","volume":"76","author":"Schwartz","year":"2016","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.05.003_bib125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.celrep.2019.07.033","article-title":"Inflammatory activation of astrocytes facilitates melanoma brain tropism via the CXCL10-CXCR3 signaling axis","volume":"28","author":"Doron","year":"2019","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007481","article-title":"CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma","volume":"11","author":"Mao","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"ement_7","key":"10.1016\/j.cytogfr.2025.05.003_bib127","doi-asserted-by":"crossref","first-page":"vii140","DOI":"10.1093\/neuonc\/noac209.540","article-title":"IMMU-43. CXCR3 signaling engages glioma infiltrating t cells and is required for the antitumor efficacy of innate stimulating immunotherapy","volume":"24","author":"Brown","year":"2022","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s12602-023-10098-y","article-title":"Hepatic symbiotic bacterium L. reuteri FLRE5K1 inhibits the development and progression of hepatocellular carcinoma via activating the IFN-\u03b3\/CXCL10\/CXCR3 pathway","volume":"16","author":"Zhang","year":"2024","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.05.003_bib129","first-page":"65","article-title":"School of nursing-camden, rutgers university, 311 N. 5","volume":"6","author":"C","year":"2014","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.08.041","article-title":"\u201cChemokines in the MPTP model of Parkinson\u2019s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration,\u201d","volume":"1128","author":"Kalkonde","year":"2007","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2010.09.042","article-title":"Neuromelanin inhibits CXCL10 expression in human astroglial cells","volume":"486","author":"Tousi","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib132","first-page":"34","article-title":"Iron in brain function and dysfunction with emphasis on Parkinson\u2019s disease","volume":"31","author":"Youdim","year":"1991","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib133","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib134","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","article-title":"Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits","volume":"114","author":"Beach","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2011.12.001","article-title":"\u03b1-Synuclein potentiates interleukin-1\u03b2-induced CXCL10 expression in human A172 astrocytoma cells","volume":"507","author":"Tousi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib136","article-title":"Cognitive status correlates with CXCL10\/IP-10 levels in Parkinson\u2019s disease","volume":"2014","author":"Rocha","year":"2014","journal-title":"Park. Dis."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2021.09.010","article-title":"Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson\u2019s disease","volume":"177","author":"Chen","year":"2021","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib138","doi-asserted-by":"crossref","unstructured":"J.A. Soria Lopez, H.M. Gonz\u00e1lez, and G.C. L\u00e9ger, \u201cAlzheimer\u2019s disease,\u201d 2019, pp. 231\u2013255. doi: 10.1016\/B978-0-12-804766-8.00013-3.","DOI":"10.1016\/B978-0-12-804766-8.00013-3"},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib139","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","article-title":"Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer\u2019s disease","volume":"108","author":"Xia","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib140","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/pr300895r","article-title":"Secretome analyses of A\u03b21-42 stimulated hippocampal astrocytes reveal that CXCL10 is involved in astrocyte migration","volume":"12","author":"Lai","year":"2013","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib141","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2006","journal-title":"Arch. Neurol."},{"issue":"5284","key":"10.1016\/j.cytogfr.2025.05.003_bib142","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib143","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11064-007-9554-z","article-title":"Decreased fractalkine and increased IP-10 expression in aged brain of APPswe transgenic mice","volume":"33","author":"Duan","year":"2008","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib144","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11064-012-0913-z","article-title":"Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer\u2019s disease mice","volume":"38","author":"Zaheer","year":"2013","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib145","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3233\/JAD-180678","article-title":"5xFAD mice display sex-dependent inflammatory gene induction during the prodromal stage of Alzheimer\u2019s disease","volume":"70","author":"Manji","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib146","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib147","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1172\/JCI66771","article-title":"CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer\u2019s disease model","volume":"125","author":"Krauthausen","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","article-title":"Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair","volume":"36","author":"Lemus","year":"2018","journal-title":"Neurol. Clin."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib150","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5+\u2009and CXCR3+\u2009T cells are increased in multiple sclerosis and their ligands MIP-1\u03b1 and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib151","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"S\u00f8rensen","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2025.05.003_bib152","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","article-title":"Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system","volume":"127","author":"Sorensen","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib153","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","article-title":"Expression of the interferon-\u03b3-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions","volume":"26","author":"Simpson","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib154","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00415-002-0699-z","article-title":"Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid","volume":"249","author":"Teleshova","year":"2002","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib155","first-page":"498","article-title":"Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis","volume":"72","author":"Mahad","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.05.003_bib156","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1191\/1352458503ms899oa","article-title":"Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse","volume":"9","author":"Mahad","year":"2003","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib157","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/1352458504ms982oa","article-title":"Distinct roles for IP-10\/CXCL10 in three animal models, Theiler\u2019s virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10","volume":"10","author":"Tsunoda","year":"2004","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib158","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.165.5.2327","article-title":"Cutting edge: the T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease","volume":"165","author":"Liu","year":"2000","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.05.003_bib159","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.05.003_bib160","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.05.003_bib161","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.168.11.5885","article-title":"Plasmid DNA encoding IFN-\u03b3-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis","volume":"168","author":"Wildbaum","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib162","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3565(25)20148-3","article-title":"Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2\/IP-10 in experimental allergic encephalomyelitis of lewis rat","volume":"278","author":"Wojcik","year":"1996","journal-title":"J. Pharm. Exp. Ther."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.05.003_bib163","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","article-title":"CXCL10 (IFN-\u03b3-Inducible Protein-10) control of encephalitogenic CD4+\u2009T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis","volume":"166","author":"Fife","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.05.003_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cytogfr.2025.05.003_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-109","article-title":"CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system","volume":"11","author":"Krauthausen","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.05.003_bib166","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.1401459","article-title":"CXCL10 triggers early microglial activation in the cuprizone model","volume":"194","author":"Clarner","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib167","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R","article-title":"\u201cNeutralization of IFN-inducible protein 10\/CXCL10 exacerbates experimental autoimmune encephalomyelitis","volume":"32","author":"Narumi","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.05.003_bib168","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4049\/jimmunol.179.5.2774","article-title":"CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system","volume":"179","author":"M\u00fcller","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib169","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.05.003_bib170","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1021\/acs.jmedchem.3c00074","article-title":"Discovery of clinical candidate ACT-777991, a potent CXCR3 antagonist for antigen-driven and inflammatory pathologies","volume":"66","author":"Meyer","year":"2023","journal-title":"J. Med Chem."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:01:58Z","timestamp":1778601718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":170,"alternative-id":["S1359610125000498"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}